ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Adult Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,588Medicare Part D Prescriptions Filled, Including Refills
$437K Total Retail Price of All Prescriptions
215 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
AMLODIPINE BESYLATE 318 253
METOPROLOL TARTRATE 271 244
SIMVASTATIN 255 234
DONEPEZIL HCL 219 197
LISINOPRIL 214 199
OMEPRAZOLE 191 140
LACTULOSE 148 130
MIRTAZAPINE 142 109
RISPERIDONE 135 109
PHENYTOIN SODIUM EXTENDED 127 78
LOVASTATIN 125 113
METOPROLOL SUCCINATE 125 116
FUROSEMIDE 123 105
HYDRALAZINE HCL 121 106
LISINOPRIL-HYDROCHLOROTHIAZIDE 109 83
NAMENDA 107 96
OXYCODONE-ACETAMINOPHEN 104 52 S2
JANTOVEN 97 97
QUETIAPINE FUMARATE 93 78
LEVETIRACETAM 92 43
METFORMIN HCL 90 59
SERTRALINE HCL 88 64
LEVOTHYROXINE SODIUM 87 82
WARFARIN SODIUM 83 59
RANITIDINE HCL 81 72
HYDROCHLOROTHIAZIDE 79 76
LIDODERM 79 53
GABAPENTIN 79 70
TAMSULOSIN HCL 74 34
TRAZODONE HCL 73 68
ATORVASTATIN CALCIUM 69 50
LANTUS 68 43
PANTOPRAZOLE SODIUM 68 48
GLIPIZIDE ER 66 50
RENVELA 65 27
ADVAIR DISKUS 64 41
LEVOFLOXACIN 64 44
TRAMADOL HCL 63 55
NITROGLYCERIN PATCH 61 61
IBUPROFEN 58 30
FAMOTIDINE 58 45
CIPROFLOXACIN HCL 56 48
ALLOPURINOL 56 42
COLCRYS 51 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.